Prevalence of Resistant Strains of Streptococcus Pneumoniae to Oxacillin, Ofloxacin and Rifampicin in Abraka South-South Nigeria

Authors

  • Felix O. Enwa

Keywords:

pneumonia; resistance; susceptibility; prevalence

Abstract

The clinical isolate Streptococcus pneumoniae is a major cause of illness such as pneumoniae, meningitis, bacteremia and otitis media in children and the elderly. The emergence of drug-resistant strains threatens to complicate the management of these diseases. An hospital-based and community-based surveillance for drug-resistant Streptococcus pneumoniae in outpatients with respiratory infection in Abraka, Delta State Nigeria was conducted. Between August - October 2014, a cross-sectional study was conducted in Abraka general hospital and Abraka community to assess the prevalence of drug resistant Streptococcus pneumoniae isolated from sputum samples of patients with cough and catarrh (respiratory tract infection). A total of 125 sputum samples of patients with respiratory tract infection were collected and inoculated on 5% sheep-blood agar, incubated at 35oC for 24hours in 5-10% CO2. Susceptibility testing panels of Ofloxacin, Rifampicin and Oxacillin were tested against isolated Streptococcus pneumoniae. Of the 125 sputum samples collected 28 (22.4%) was positive for Streptococcus pneumoniae. 18 out of 75male adults (24%) and 10 out of 50female adults (20%) were positive for Streptococcus pneumoniae. Also from the result, samples that were positive for Streptococcus pneumoniae when considered in terms of age group, showed that adults between 20-25 years had the highest prevalence rate of (31%) when compared to those in patients between 26 -30years which was (13%). Susceptibility studies showed that the highest resistance of Streptococcus pneumoniae was observed in the use of oxacillin and rifampicin which gave no zone of inhibition and highest sensitivity was observed in the use of ofloxacin with percentage inhibition 74.3%.

How to Cite

Prevalence of Resistant Strains of Streptococcus Pneumoniae to Oxacillin, Ofloxacin and Rifampicin in Abraka South-South Nigeria. (2015). Global Journal of Medical Research, 15(33), 15-20. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Author Biography

Felix O. Enwa

Felix O. Enwa is a dedicated academic and researcher in the field of pharmaceutical microbiology, currently affiliated with Delta State University in Abraka, Nigeria. He serves as a lecturer and researcher in the Department of Pharmaceutical Microbiology, where he investigates antimicrobial resistance, medicinal plants, and public health microbiology. Dr. Enwa holds a Ph.D. in Pharmaceutical Microbiology and Biotechnology from Nnamdi Azikiwe University, an M.Sc. in Food Quality & Safety (Microbiology) from the University of Plymouth, and a B.MLS in Medical Laboratory Sciences from Ambrose Alli University. His notable works include studies on the comparative efficacy of alcohol-based hand sanitizers and toilet soaps against bacterial isolates, as well as the prevalence of resistant Streptococcus pneumoniae strains in South-South Nigeria. With 45 publications, 96 citations, an h-index of 6, and an i10-index of 2, his research contributes significantly to understanding infectious diseases and the therapeutic potential of local medicinal plants.

References

Al-Jasser AM (2006) Stenotrophomonas maltophilia resistant to trimethoprim sulfamethoxazole: an increasing problem. 5, 23-26.

Robert Austrian (1986) Some aspects of the pneumococcal carrier state. 18(Supplement_A), 35-45. https://doi.org/10.1093/jac/18.supplement_a.35

J. Barlett, R. Breiman, L. Mandell, Jr T.M. File (1998) Community-acquired pneumonia in adults: Guidelines for management. The lnfectious Diseases Society of America. Clin. Lnfect. 26, 811-838.

Borer A, Meirson H, Peled N, Porat N, Dagan R, Fraser D (2001) Antibiotic‐Resistant Pneumococci Carried by Young Children Do Not Appear to Disseminate to Adult Members of a Closed Community. 33, 436-444.

(1993) Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. 270, 1826-1831.

CDC (2003) Epidemiology and Prevention of Vaccine-Preventable Diseases.

The book (2004) http://www.cdc.gov/nip/publications/pink/default.ht

S. Kaplan, Jr E.O Mason (1998) Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin. Microbiol. 11, 628-644.

H. Knothe, P. Shah, V. Krcmery, M. Antal, S. Mitsuhashi (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. 11(6), 315-317. https://doi.org/10.1007/bf01641355

James Rahal (2006) Novel Antibiotic Combinations against Infections with Almost Completely Resistant Pseudomonas aeruginosa and Acinetobacter Species.Journal of Clinical Infectious Diseases. 43(Supplement_2), S95-S99. https://doi.org/10.1086/504486

A. Sekowska, G. Janicka, M. Wojda, M. Wróblewski, M. Szymankiewicz (2002) Resistance of Klebsiella pneumonia strains producing and not producing ESBL (extended-spectrum betalactam- ase) type enzymes to selected non-beta-lactam antibiotics. (3), 100-104.

Monica Cheesbrough (2004) District laboratory practice in tropical countries part 2. 141-142. https://doi.org/10.1017/cbo9780511581304

Prevalence of Resistant Strains of Streptococcus Pneumoniae to Oxacillin, Ofloxacin and Rifampicin in Abraka South-South Nigeria

Published

2015-09-21

How to Cite

Prevalence of Resistant Strains of Streptococcus Pneumoniae to Oxacillin, Ofloxacin and Rifampicin in Abraka South-South Nigeria. (2015). Global Journal of Medical Research, 15(33), 15-20. https://medicalresearchjournal.org/index.php/GJMR/article/view/